LABORATORY AND CLINICAL EVALUATION OF A NEW ANTIBIOTIC--CEPHALOTHIN.
D000900:Anti-Bacterial Agents; D002512:Cephalothin; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004358:Drug Therapy; D004755:Enterobacteriaceae; D004927:Escherichia coli Infections; D006069:Gonorrhea; D007709:Klebsiella; D011014:Pneumonia; D011512:Proteus Infections; D011704:Pyelonephritis; D018805:Sepsis; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D014116:Toxicology; D014552:Urinary Tract Infections
D000900:Anti-Bacterial Agents; D002512:Cephalothin
ANTIBIOTICS; CEPHALOTHIN; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; GONORRHEA; KLEBSIELLA; PARACOLOBACTRUM; PNEUMONIA; PROTEUS INFECTIONS; PYELONEPHRITIS; SEPTICEMIA; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TOXICOLOGIC REPORT; URINARY TRACT INFECTIONS